Results of a phase 2 study of HGS-ETR1, a fully human agonistic monoclonal antibody to TRAIL Receptor 1, in subjects with relapsed or refractory colorectal cancer (CRC) | Health & Environmental Research Online (HERO)

Health & Environmental Research Online (HERO)

Print Feedback Export to File

This record has one attached file:

Citation
Tags

HERO ID

4193395

Reference Type

Journal Article

Title

Results of a phase 2 study of HGS-ETR1, a fully human agonistic monoclonal antibody to TRAIL Receptor 1, in subjects with relapsed or refractory colorectal cancer (CRC)

Author(s)

Kanzler, S; Trarbach, T; Heinemann, V; Koehne, CH; Sneller, V; Bieber, F; Galle, PR; Seeber, S

Year

2005

Is Peer Reviewed?

Journal

European Journal of Cancer Supplements
ISSN: 1359-6349

Volume

Issue

Page Numbers

178-178

Web of Science Id

WOS:000247564800608